Bildkälla: Stockfoto

ChromoGenics: Robust order intake signals potential sales growth next year - Redeye

Redeye provides an update on ChromoGenics following the company's Q3 2023 results. New cooperations with strong order intatake signalls a potential turnaround. We estimate sales to double next year.

Redeye provides an update on ChromoGenics following the company's Q3 2023 results. New cooperations with strong order intatake signalls a potential turnaround. We estimate sales to double next year.
Börsvärldens nyhetsbrev
ANNONSER